Scientists test if new skin drug changes how birth control and blood thinners work
NCT ID NCT07190430
Summary
This early-stage study aims to understand how an experimental atopic dermatitis (eczema) drug called PF-08049820 affects how other medications move through the body. Researchers will test 16 healthy adult women to see if taking this drug changes how birth control pills, a sedative (midazolam), and a blood thinner (dabigatran) work. The study will help determine if future patients could safely take this eczema treatment alongside their other medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.